Early research (Phase 1)Study completedNCT01769755
What this trial is testing
A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease
Who this might be right for
Crohns Disease
Celularity Incorporated 14